Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1960 1
1961 2
1962 1
1963 2
1964 2
1965 4
1967 3
1968 5
1969 3
1970 5
1971 5
1972 2
1973 3
1974 1
1975 3
1976 2
1977 1
1979 4
1980 4
1981 3
1982 1
1984 1
1985 2
1986 4
1987 4
1988 3
1989 4
1990 1
1991 6
1992 9
1993 10
1994 4
1995 12
1996 9
1997 5
1998 5
1999 14
2000 9
2001 6
2002 9
2003 6
2004 2
2005 3
2006 4
2007 1
2008 5
2009 3
2010 3
2011 11
2012 6
2013 12
2014 11
2015 8
2016 7
2017 11
2018 9
2019 16
2020 6
2021 5
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators. Matsushita T, et al. N Engl J Med. 2023 Aug 31;389(9):783-794. doi: 10.1056/NEJMoa2216455. N Engl J Med. 2023. PMID: 37646676 Clinical Trial.
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF; A-LONG Investigators. Mahlangu J, et al. Blood. 2014 Jan 16;123(3):317-25. doi: 10.1182/blood-2013-10-529974. Epub 2013 Nov 13. Blood. 2014. PMID: 24227821 Free PMC article. Clinical Trial.
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
Pipe SW, Shima M, Lehle M, Shapiro A, Chebon S, Fukutake K, Key NS, Portron A, Schmitt C, Podolak-Dawidziak M, Selak Bienz N, Hermans C, Campinha-Bacote A, Kiialainen A, Peerlinck K, Levy GG, Jiménez-Yuste V. Pipe SW, et al. Among authors: fukutake k. Lancet Haematol. 2019 Jun;6(6):e295-e305. doi: 10.1016/S2352-3026(19)30054-7. Epub 2019 Apr 16. Lancet Haematol. 2019. PMID: 31003963 Clinical Trial.
Adult Morquio syndrome requiring occipito-thoracic fusion.
Okumura R, Hasegawa K, Tsuge S, Fukutake K, Nakamura K, Takahashi H, Wada A. Okumura R, et al. Among authors: fukutake k. J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(2):2309499020918424. doi: 10.1177/2309499020918424. J Orthop Surg (Hong Kong). 2020. PMID: 32329403 Free article.
Oral cancer research with an emphasis on genomic analysis.
Shibahara T, Noma H, Kakizawa T, Ohtsuru H, Fukutake K, Uchida I. Shibahara T, et al. Among authors: fukutake k. Bull Tokyo Dent Coll. 2002 Nov;43(4):209-22. doi: 10.2209/tdcpublication.43.209. Bull Tokyo Dent Coll. 2002. PMID: 12687726 Free article. Review.
[Factor V].
Fukutake K, Fukue H. Fukutake K, et al. Nihon Rinsho. 1999 Sep;57 Suppl:597-9. Nihon Rinsho. 1999. PMID: 10543188 Review. Japanese. No abstract available.
[Factor V].
Fukutake K, Sato T. Fukutake K, et al. Nihon Rinsho. 1995 Mar;53 Su Pt 2:68-70. Nihon Rinsho. 1995. PMID: 8753182 Review. Japanese. No abstract available.
294 results